Citation: | LI Lijuan, WU Jie, SHANG Xinxiu, FENG Weixun. Efficacy of Xingpi Huazhuo Prescription in treating pre-diabetic patients with phlegm-dampness constitution and its influences on blood glucose and renal function indexes[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 60-63. DOI: 10.7619/jcmp.20242530 |
To investigate the efficacy of Xingpi Huazhuo Prescription in treating pre-diabetic patients with phlegm-damp constitution and its impacts on blood glucose levels and renal function indicators.
A total of 104 pre-diabetic patients with phlegm-damp constitution admitted to the hospital between January 2021 and December 2023 were selected and randomly divided into western medicine group (n=52) and combined group (n=52) using a random number table method. The western medicine group received metformin treatment, while the combined group received metformin combined with Xingpi Huazhuo Prescription. Clinical efficacy was recorded after 3 months of treatment, and blood glucose indexes such as [fasting blood glucose (FPG), glycated hemoglobin (HbA1c), and 2-h plasma glucose (2 hPG)] levels, lipid indicators[triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C)], and renal function indicators [serum creatinine (Scr), urea nitrogen (BUN), β2-microglobulin (β2-MG)] were compared before and after 3 months of treatment.
After 3 months of treatment, the total clinical effectiveness in the combined group was higher than that in the western medicine group (P < 0.05). After 3 months of treatment, the levels of FPG, HbA1c, and 2 hPG decreased in both groups, and the combined group showed lower levels than the western medicine group (P < 0.05). After 3 months of treatment, the levels of TG, TC, and LDL-C decreased in both groups compared with before treatment, and the combined group showed lower levels than the western medicine group (P < 0.05); the levels of HDL-C increased in both groups, and the combined group showed higher levels than the western medicine group (P < 0.05). After 3 months of treatment, the levels of Scr, BUN, and β2-MG decreased in both groups, with the combined group showing lower levels than the western medicine group (P < 0.05).
In pre-diabetic patients with phlegm-damp constitution, metformin combined with Xingpi Huazhuo Prescription can effectively improve blood glucose levels and exert renal protective effects.
[1] |
LUO X J, WANG Z Z, LI B W, et al. Effect of resistance vs. aerobic exercise in pre-diabetes: an RCT[J]. Trials, 2023, 24(1): 110. doi: 10.1186/s13063-023-07116-3
|
[2] |
陈怡, 彭年春, 张淼, 等. 贵阳城区40岁及以上不同亚型糖尿病前期人群10年心血管疾病发生风险的队列研究[J]. 中华内分泌代谢杂志, 2024, 40(5): 373-379.
|
[3] |
李玲, 朱磊, 侯稳, 等. 糖尿病前期脑出血患者的临床特征及预后分析[J]. 实用临床医药杂志, 2023, 27(5): 119-122, 127. doi: 10.7619/jcmp.20223485
|
[4] |
张祯, 李克明, 徐鑫. 桃仁承气汤化裁联合西医序贯治疗2型糖尿病患者的效果[J]. 实用临床医药杂志, 2023, 27(20): 122-126. doi: 10.7619/jcmp.20232251
|
[5] |
高彦彬, 倪青, 徐云生, 等. 糖尿病前期(脾瘅)中医诊疗优化方案(2023版)[J]. 世界中西医结合杂志, 2023, 18(5): 1046-1050.
|
[6] |
中华医学会内分泌学分会, 中华医学会糖尿病学分会, 中国医师协会内分泌代谢科医师分会, 等. 中国成人糖尿病前期干预的专家共识[J]. 中华内分泌代谢杂志, 2020, 36(5): 371-380.
|
[7] |
中华中医药学会糖尿病分会. 糖尿病前期中医诊疗标准[J]. 世界中西医结合杂志, 2011, 6(5): 446-449.
|
[8] |
中华中医药学会. 糖尿病中医防治指南[M]. 北京: 中国中医药出版社, 2007: 1-3.
|
[9] |
赵加, 王倩, 苑浩彬, 等. 六君子汤加味穴位贴敷治疗脾虚痰湿型糖尿病前期肥胖患者的疗效及对患者炎症因子和肠道菌群的影响[J]. 河北中医, 2023, 45(7): 1150-1155.
|
[10] |
张慧芬, 周宇清, 吴倩莹, 等. 黄芪消积化浊汤治疗糖尿病前期脾虚痰湿证患者的疗效及安全性研究[J]. 中医药导报, 2023, 29(12): 53-56, 83.
|
[11] |
WANG S, DU S S, WANG W Z, et al. Therapeutic investigation of quercetin nanomedicine in a zebrafish model of diabetic retinopathy[J]. Biomedecine Pharmacother, 2020, 130: 110573.
|
[12] |
JIA W J, BI Q M, JIANG S R, et al. Hypoglycemic activity of Codonopsis pilosula (Franch. ) Nannf. In vitro and in vivo and its chemical composition identification by UPLC-Triple-TOF-MS/MS[J]. Food Funct, 2022, 13(5): 2456-2464.
|
[13] |
金丽霞, 张雨晴, 金丽军, 等. 加味参芪地黄汤联合穴位注射治疗气阴两虚血瘀型Ⅲ~Ⅳ期糖尿病肾病临床观察[J]. 现代中西医结合杂志, 2023, 32(24): 3422-3426.
|
[14] |
WANG X J, ZHOU W E, WANG Q, et al. A novel and comprehensive strategy for quality control in complex Chinese medicine formula using UHPLC-Q-Orbitrap HRMS and UHPLC-MS/MS combined with network pharmacology analysis: take Tangshen formula as an example[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2021, 1183: 122889.
|
[15] |
冯静, 李玲玲, 崔瑛. 茯苓对阴虚水肿模型大鼠及其热象的影响[J]. 中草药, 2023, 54(2): 586-592.
|
[16] |
魏蜀吴, 孙卫卫, 姜伟民, 等. 痰湿与2型糖尿病脂代谢紊乱的相关性临床研究[J]. 浙江中医药大学学报, 2022, 46(10): 1136-1140.
|